{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T21:03:06Z","timestamp":1768251786338,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.hpb.2019.10.014","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T03:00:13Z","timestamp":1573700413000},"page":"900-910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparative analysis of outcomes after liver resection and liver transplantation for early stages hepatocellular carcinoma in HIV-infected patients. An intention-to-treat analysis"],"prefix":"10.1016","volume":"22","author":[{"given":"Nicolas","family":"Golse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiane","family":"B\u00fcndchen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Karam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-A.","family":"Allard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Pittau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oriana","family":"Ciacio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-C.","family":"Duclos-Vall\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sa Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Castaing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Cherqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9","family":"Adam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Vibert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.hpb.2019.10.014_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081355","article-title":"Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada","volume":"8","author":"Samji","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.hpb.2019.10.014_bib2","first-page":"1","article-title":"HIV\/HCV co-infected cirrhotic patients are no longer at higher risk for HCC or end-stage liver disease as compared to HCV mono-infected patients","author":"Salmon-C\u00e9ron","year":"2018","journal-title":"Hepatology"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.hpb.2019.10.014_bib3","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.jhep.2005.11.009","article-title":"Natural history and predictors of disease severity in chronic hepatitis C","volume":"44","author":"Massard","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.hpb.2019.10.014_bib4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/hep.21990","article-title":"Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus","volume":"47","author":"Duclos-Vall\u00e9e","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2019.10.014_bib5","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/QAD.0b013e32832c2a37","article-title":"Long-term follow-up of liver transplanted HIV\/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity","volume":"23","author":"Tateo","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.hpb.2019.10.014_bib6","series-title":"International liver transplantation society consensus statement on hepatitis C management in liver transplant recipients","first-page":"956","author":"Terrault","year":"2017"},{"key":"10.1016\/j.hpb.2019.10.014_bib7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3748\/wjg.v24.i3.315","article-title":"Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates","volume":"24","author":"Gadiparthi","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hpb.2019.10.014_bib8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1148\/radiol.2015141500","article-title":"Imaging features and prognosis of hepatocellular carcinoma in patients with cirrhosis who are coinfected with human immunodeficiency virus and hepatitis C virus","volume":"277","author":"Lewin","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.hpb.2019.10.014_bib9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/liv.13921","article-title":"Prognostic factors of survival in HIV\/HCV co-infected patients with hepatocellular carcinoma: the CARCINOVIC Cohort","volume":"39","author":"Gelu-Simeon","year":"2019","journal-title":"Liver Int"},{"issue":"4","key":"10.1016\/j.hpb.2019.10.014_bib10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/hiv.12204","article-title":"Liver-related deaths in HIV-infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalit\u00e9 2010 survey","volume":"16","author":"Rosenthal","year":"2015","journal-title":"HIV Med"},{"key":"10.1016\/j.hpb.2019.10.014_bib11","first-page":"3619","article-title":"Clinical presentation and outcome of non-AIDS defining cancers, in HIV-infected patients in the ART-era: the Italian Cooperative Group on AIDS and tumors activity","volume":"19","author":"Berretta","year":"2015","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.hpb.2019.10.014_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/jvh.13022","article-title":"Liver transplant listing for hepatitis C-associated cirrhosis and hepatocellular carcinoma has fallen in the United Kingdom since the introduction of direct-acting antiviral therapy","volume":"26","author":"Vaziri","year":"2019","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.hpb.2019.10.014_bib13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.clinre.2011.11.002","article-title":"Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir)","volume":"36","author":"Bourcier","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.hpb.2019.10.014_bib14","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/00002030-200411190-00009","article-title":"Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome","volume":"18","author":"Puoti","year":"2004","journal-title":"AIDS"},{"issue":"1","key":"10.1016\/j.hpb.2019.10.014_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0002-9270(00)02167-5","article-title":"Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C","volume":"96","author":"Garc\u00eda-Samaniego","year":"2001","journal-title":"Am J Gastroenterology"},{"key":"10.1016\/j.hpb.2019.10.014_bib16","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ejso.2007.05.004","article-title":"Hepatocellular carcinoma in HIV patients treated by liver transplantation","volume":"34","author":"Di Benedetto","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hpb.2019.10.014_bib17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/hep.24062","article-title":"Liver transplantation for hepatocellular carcinoma: the impact of human immunodeficiency virus infection","volume":"53","author":"Vibert","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2019.10.014_bib18","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/hep.28321","article-title":"Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma","volume":"63","author":"Ag\u00fcero","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2019.10.014_bib19","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1634\/theoncologist.2012-0255","article-title":"Multicenter Italian experience in liver transplantation for hepatocellular carcinoma in HIV-infected patients","volume":"18","author":"Di Benedetto","year":"2013","journal-title":"The Oncologist"},{"key":"10.1016\/j.hpb.2019.10.014_bib20","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.3748\/wjg.v20.i18.5353","article-title":"Pros and cons of liver transplantation in human immunodeficiency virus infected recipients","volume":"20","author":"Baccarani","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.hpb.2019.10.014_bib21","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jhep.2014.10.032","article-title":"Outcome and management of HCV\/HIV coinfection pre- and post-liver transplantation. A 2015 update","volume":"62","author":"Miro","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.hpb.2019.10.014_bib22","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"European association for the study of the liver., European association for the study of the liver. EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.hpb.2019.10.014_bib23","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hpb.2019.10.014_bib24","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/j.gastro.2012.05.052","article-title":"Liver transplantation for hepatocellular carcinoma: a model including \u03b1-fetoprotein improves the performance of Milan criteria","volume":"143","author":"Duvoux","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2019.10.014_bib25","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"European Association for the Study of the Liver","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.hpb.2019.10.014_bib26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24","author":"Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2019.10.014_bib27","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/jama.1993.03500060023008","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults","volume":"269","author":"From the Centers for Disease Control and Prevention","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.hpb.2019.10.014_bib28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S2468-1253(16)30008-5","article-title":"Optimum timing of treatment for hepatitis C infection relative to liver transplantation","volume":"1","author":"Coilly","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.hpb.2019.10.014_bib29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s40506-018-0144-1","article-title":"Solid organ transplantation for HIV-infected individuals","volume":"10","author":"Shaffer","year":"2018","journal-title":"Curr treat options infect dis"},{"key":"10.1016\/j.hpb.2019.10.014_bib30","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/jnci\/djn134","article-title":"Design and endpoints of clinical trials in hepatocellular carcinoma","volume":"100","author":"Llovet","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.hpb.2019.10.014_bib31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/TP.0000000000001928","article-title":"Sofosbuvir-based regimens in HIV\/HCV coinfected patients after liver transplantation: results from the ANRS CO23 CUPILT study","volume":"102","author":"Antonini","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.hpb.2019.10.014_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/QAD.0000000000000516","article-title":"Therapy with boceprevir or telaprevir in HIV\/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation","volume":"29","author":"Antonini","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.hpb.2019.10.014_bib33","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1053\/j.gastro.2018.07.015","article-title":"Incidence of hepatocellular carcinoma after direct antiviral therapy for HCV in patients with cirrhosis included in surveillance programs","volume":"155","author":"Nahon","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2019.10.014_bib34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jhep.2018.09.029","article-title":"Impact of direct-acting antivirals on early recurrence of HCV-related HCC: comparison with interferon-based therapy","volume":"70","author":"Nishibatake Kinoshita","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.hpb.2019.10.014_bib35","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jhep.2017.07.025","article-title":"Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: a systematic review, meta-analyses, and meta-regression","volume":"67","author":"Waziry","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.hpb.2019.10.014_bib36","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1111\/ajt.14996","article-title":"Direct-acting antivirals are effective and safe in HCV\/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: a prospective nationwide cohort study","volume":"18","author":"Manzardo","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hpb.2019.10.014_bib37","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/QAD.0000000000001422","article-title":"Hepatocellular carcinoma: an evolving challenge in viral hepatitis and HIV coinfection","volume":"31","author":"Pinato","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.hpb.2019.10.014_bib38","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/tid.12422","article-title":"Infectious complications after liver transplantation in human immunodeficiency virus-infected recipients","volume":"17","author":"Teicher","year":"2015","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.hpb.2019.10.014_bib39","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jhep.2007.06.010","article-title":"Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study","volume":"47","author":"Br\u00e4u","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.hpb.2019.10.014_bib40","first-page":"e490.1","article-title":"Liver Resection for HCC in HIV-infected patients: a single center experience","volume":"2","author":"D'Amico","year":"2015","journal-title":"WCRJ"},{"key":"10.1016\/j.hpb.2019.10.014_bib41","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1634\/theoncologist.2010-0400","article-title":"Hepatocellular carcinoma in HIV-infected patients: check early, treat hard","volume":"16","author":"Berretta","year":"2011","journal-title":"The Oncologist"},{"key":"10.1016\/j.hpb.2019.10.014_bib42","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/QAI.0b013e31826ebdc7","article-title":"Standardized care management ensures similar survival rates in HIV-positive and HIV-negative patients with hepatocellular carcinoma","volume":"61","author":"Lim","year":"2012","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.hpb.2019.10.014_bib43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00534-003-0876-1","article-title":"Operated hepatocellular carcinoma in two HIV- and HCV-positive hemophilic patients","volume":"11","author":"Narushima","year":"2004","journal-title":"J\u00a0Hepatobiliary Pancreat Surg"},{"issue":"Suppl.\u00a04","key":"10.1016\/j.hpb.2019.10.014_bib44","first-page":"167","article-title":"Resection and transplantation: evaluation of surgical perspectives in HIV positive patients affected by end-stage liver disease","volume":"22","author":"Ettorre","year":"2003","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.hpb.2019.10.014_bib45","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cgh.2012.08.010","article-title":"Presentation, treatment, and clinical outcomes of patients with hepatocellular carcinoma, with and without human immunodeficiency virus infection","volume":"10","author":"Yopp","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2019.10.014_bib46","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0002-9610(01)00584-0","article-title":"Hepatic resection for large hepatocellular carcinoma","volume":"181","author":"Hanazaki","year":"2001","journal-title":"Am J Surg"},{"key":"10.1016\/j.hpb.2019.10.014_bib47","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jso.10178","article-title":"Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis","volume":"81","author":"Yeh","year":"2002","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.hpb.2019.10.014_bib48","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/lt.24758","article-title":"Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: an attempt to perform an ideal meta-analysis","volume":"23","author":"Menahem","year":"2017","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hpb.2019.10.014_bib49","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/SLA.0b013e318273bad0","article-title":"Resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy?","volume":"256","author":"Adam","year":"2012","journal-title":"Ann Surg"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X19307476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X19307476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:27:53Z","timestamp":1761265673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X19307476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S1365182X19307476"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2019.10.014","relation":{},"ISSN":["1365-182X"],"issn-type":[{"value":"1365-182X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative analysis of outcomes after liver resection and liver transplantation for early stages hepatocellular carcinoma in HIV-infected patients. An intention-to-treat analysis","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2019.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}